Corvus Pharmaceuticals to Present New CPI-818 Data at the International Conference on Malignant Lymphoma
BURLINGAME, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
Year: 2023
Corvus Pharmaceuticals to Present New CPI-818 Data at the International Conference on Malignant Lymphoma
BURLINGAME, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
Umoja Biopharma Presents New Preclinical Data at the American Society of Gene and Cell Therapy 26th Annual Meeting Demonstrating Potent In Vivo CAR T Cell Generation and Durable Anti-Tumor Activity
UB-VV200 preclinical data highlight successful generation of TagCAR T cells, which demonstrate dose-dependent anti-tumor activity…
Umoja Biopharma Presents New Preclinical Data at the American Society of Gene and Cell Therapy 26th Annual Meeting Demonstrating Potent In Vivo CAR T Cell Generation and Durable Anti-Tumor Activity
UB-VV200 preclinical data highlight successful generation of TagCAR T cells, which demonstrate dose-dependent anti-tumor activity…
LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641, Its First-in-Class, Orally Administered Tim3/4 Agonist for Treg Expansion to Treat Autoimmune Diseases
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused…
LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641, Its First-in-Class, Orally Administered Tim3/4 Agonist for Treg Expansion to Treat Autoimmune Diseases
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused…
XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares
AUSTIN, Texas, May 17, 2023 (GLOBE NEWSWIRE) — Xbiotech Inc. (NASDAQ: XBIT) (“Xbiotech”) announced today…
XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares
AUSTIN, Texas, May 17, 2023 (GLOBE NEWSWIRE) — Xbiotech Inc. (NASDAQ: XBIT) (“Xbiotech”) announced today…
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv,…
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv,…
Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
Shockwave Appoints Kevin Ballinger to Board of Directors
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Shockwave Appoints Kevin Ballinger to Board of Directors
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
ORYZON to Present Trial in Progress Phase Ib FRIDA Study at the Upcoming 2023 ASCO Annual Meeting
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
ORYZON to Present Trial in Progress Phase Ib FRIDA Study at the Upcoming 2023 ASCO Annual Meeting
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…